Exome Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-193,600
Closed -$1.76M 64
2024
Q1
$1.76M Buy
+193,600
New +$1.76M 1.51% 28